Theralase Technologies Inc. V.TLT

Alternate Symbol(s): TLTFF

Healthcare Medical Devices

Theralase Technologies Inc. is a Canada-based clinical-stage pharmaceutical company. The Company is engaged in the research and development of light activated compounds and their associated drug formulations. The Company operates through two divisions: Anti-Cancer Therapy (ACT) and Cool Laser Therapy (CLT). The Anti-Cancer Therapy division develops patented, and patent pending drugs, called Photo Dynamic Compounds (PDCs) and activates them with patent pending laser technology to destroy specifically targeted cancers, bacteria and viruses. The CLT division is responsible for the Company’s medical laser business. The Cool Laser Therapy division designs, develops, manufactures and markets super-pulsed laser technology indicated for the healing of chronic knee pain. The technology has been used off-label for healing numerous nerve, muscle and joint conditions. The Company develops products both internally and using the assistance of specialist external resources.

TSXV:TLT - Post by User

Theralase Technologies Inc. > Timeline

<< Previous

Bullboard Posts

Next >>

Post by Eoganachton Jun 23, 2023 2:08pm

426 Views

Post# 35511720

Timeline

We've treated 60 patients and it looks like we're only going to treat 40 more. If we continue treating 3 patients per month we will be finished the treatment phase by the end of July 2024. The 100th patient should receive their 450 day assessment by the end of October 2025. The data will be compiled and application to the FDA for approval to commercialize made in late 2025 or early 2026.

IMHO Roger was bang on with the timeline this time.

"In order to line this up and get all the clinical data in place and get this into a position for marketing approval which we hope to do in 2025, early 2026"

<< Previous

Bullboard Posts

Next >>

The Market Online’s Weekly Gold Report – Nov. 27, 2024